NSE: APOLLOHOSP · NIFTY 50

Apollo Hospitals Share Price

Company information and financial fundamentals for Apollo Hospitals, alongside its latest NSE share price.

Last price₹8,408.50+3.34% today · prev close ₹8,137.00
SectorHealthcare

About Apollo Hospitals

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country.

Sector: Healthcare · NSE symbol: APOLLOHOSP · Index: NIFTY 50

Company fundamentals

Market Cap₹ 1,19,814 Cr.
Current Price₹ 8,333
High / Low₹ 9,327 / 6,680
Stock P/E57.0
Book Value₹ 659
Dividend Yield0.24 %
ROCE17.4 %
ROE21.2 %
Face Value₹ 5.00

Figures are as reported by the company and compiled by screener.in (fetched 2026-11-03); they may lag the latest filing. Educational information, not investment advice.

Quarterly results (₹ crore)

Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales4,9445,0865,5895,5275,5925,8426,3046,4776,6067,044
Expenses4,3034,4104,7744,7654,8224,9905,3625,5125,5945,951
Operating Profit6406758167627708529419651,0111,092
OPM %13%13%15%14%14%15%15%15%15%16%
Other Income37494469725461485462
Interest119116118110115108110113119120
Depreciation190177184185211215218219224235
Profit before tax368430557536516583675682722799
Tax %30%27%29%29%20%24%27%24%24%24%
Net Profit258316396379414441494516551610
EPS in Rs17.6521.2326.3425.8927.1030.1033.1934.9336.8140.39
Raw PDF——————————

Profit and loss, yearly (₹ crore)

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales8,2439,61711,24710,56014,66316,61219,05921,79425,22826,430
Expenses7,4428,5489,6569,42012,47414,54816,66518,76121,44922,420
Operating Profit8011,0701,5911,1402,1892,0652,3943,0333,7794,010
OPM %10%11%14%11%15%12%13%14%15%15%
Other Income242622210336875123222207226
Interest295327533449379381449458450462
Depreciation359396620573601615687758876896
Profit before tax1713736602211,5781,1441,3802,0392,6612,877
Tax %65%47%34%38%30%22%32%26%25%—
Net Profit602004321371,1088449351,5052,0032,172
EPS in Rs8.4416.9632.7010.4673.4256.9762.50100.56135.04145.32
Dividend Payout %59%35%18%29%16%26%26%13%15%—

Compounded growth

Compounded Sales Growth10 Years 15%5 Years 19%3 Years 15%TTM 17%
Compounded Profit Growth10 Years 23%5 Years 76%3 Years 32%TTM 34%
Stock Price CAGR10 Years 21%5 Years 14%3 Years 18%1 Year 8%
Return on Equity10 Years 13%5 Years 17%3 Years 18%Last Year 21%

Balance sheet (₹ crore)

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital70707070727272727272
Reserves3,2443,1823,2643,2704,5315,5516,1266,8648,1409,408
Borrowings3,1253,4273,6733,5964,1604,0684,3325,3337,8648,493
Other Liabilities1,6651,9172,1594,3542,6293,5703,8864,4744,5684,210
Total Liabilities8,1038,5969,16611,28911,39213,26114,41616,74220,64422,183
Fixed Assets4,5914,7734,9827,4326,7788,2968,5209,66410,98812,272
CWIP347712822236234466108739211,032
Investments4063524624341,3438165749862,4872,179
Other Assets2,7592,7592,9013,1873,0374,1044,7125,2196,2486,700
Total Assets8,1038,5969,16611,28911,39213,26114,41616,74220,64422,183

Cash flows (₹ crore)

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity6235379051,2931,2651,6961,3771,9202,1362,856
Cash from Investing Activity-1,152-405-711-289-880-747-857-1,537-3,383-2,145
Cash from Financing Activity477-108-215-910-340-792-633-3111,319-478
Net Cash Flow-5224-209444158-1137273233
Free Cash Flow-46-842337829841,044252785439925
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit103%83%103%100%108%87%85%100%86%92%

Efficiency ratios

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days38373933464449485150
Inventory Days47514649162117171615
Days Payable51555660747982887263
Cash Conversion Cycle34332922-12-14-16-23-63
Working Capital Days278-3-8-45-1-19-6-25
ROCE %8%7%10%14%8%17%14%15%17%17%

Shareholding pattern (%)

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters29.33%29.33%29.33%29.34%29.34%28.02%28.02%28.02%28.02%28.02%
FIIs43.92%45.37%45.27%42.74%43.49%44.20%43.54%42.62%41.49%43.19%
DIIs21.13%19.94%19.97%22.29%21.34%21.12%21.50%22.76%23.72%22.07%
Government0.23%0.23%0.23%0.23%0.23%0.23%0.23%0.23%0.23%0.23%
Public5.38%5.12%5.21%5.41%5.61%6.43%6.71%6.39%6.53%6.49%
No. of Shareholders1,27,7541,19,2451,27,8021,34,0581,41,0071,60,5561,78,6481,74,6101,74,2811,72,863

Exchange disclosures

Next results date

Apollo Hospitals has a board meeting for financial results listed on 2026-11-04. Companies can reschedule; check the company's own announcement. Results calendar

Shown as filed with NSE. A filing shows that something happened, not why, and says nothing about what to do.

More on Apollo Hospitals

Quarterly resultsShareholding pattern

Compare APOLLOHOSP with CIPLA →

Wondering what to do with Apollo Hospitals?

This page shares company information and reported fundamentals. It does not tell you whether to buy, hold or sell. For a view that takes your own holding and goal into account, ask Samjho Bhai, our portfolio review tool.

Ask Samjho Bhai about APOLLOHOSP →

How this page works · New to company fundamentals? Start learning.

Key terms: Nifty 50 · Price-to-earnings ratio · Earnings per share · Dividend yield · Market capitalisation

Other Healthcare stocks in the NIFTY 50

CiplaNSE: CIPLADr. Reddy's LaboratoriesNSE: DRREDDYMax HealthcareNSE: MAXHEALTHSun PharmaNSE: SUNPHARMA

Where Apollo Hospitals sits in the market

Frequently asked questions

What is the NSE symbol for Apollo Hospitals?

Apollo Hospitals trades on the NSE under the symbol APOLLOHOSP.

Is Apollo Hospitals part of the NIFTY 50?

Yes. Apollo Hospitals is in the NIFTY 50 index (and so also in the NIFTY 500) and is classified under the Healthcare sector. Index membership is rebalanced twice a year by NSE Indices.

Should I buy Apollo Hospitals shares?

Market Dekho does not give buy, sell or hold recommendations and is not a SEBI-registered Research Analyst or Investment Adviser. To review a holding against your own goal and risk, you can use Samjho Bhai, or speak to a SEBI-registered adviser.

Prices are delayed and sourced from a public market-data provider; they may contain errors. This page is educational information, not investment advice.